We're making headlines

We're on a mission to transform medical research, for good. And people are taking notice.

AI TechPark: Antidote announced partnership with SEQSTER

PharmaShots: Antidote Technologies and SEQSTER Join Forces to Improve Patient Identification & Enrollment for Clinical Trials

IT Digest: Antidote Partners with SEQSTER to Accelerate Patient Identification & Enrollment for Clinical Trials

Antidote Partners with SEQSTER to Accelerate Patient Identification & Enrollment for Clinical Trials

The Multiple Sclerosis Association of America Proudly Announces the 10th Improving Lives Benefit in Support of the MS Community

BTSQ Magazine "Solving Clinical Trial Delays by Accelerating Patient Recruitment"

Antidote and Melanoma Research Alliance join forces to enhance clinical trial search for people impacted by melanoma

Antidote se une a Beyond Type 1 y JDRF para lanzar el primer buscador de ensayos clínicos en español sobre diabetes tipo 1 (DM1)

Antidote joins forces with Beyond Type 1 and JDRF to launch the first-ever Spanish-language clinical trial search engine for type 1 diabetes (T1D)

Antidote Technologies receives high marks in cybersecurity risk assessment

Press Contact
media-kit-cta